Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001174574 | SCV001337737 | benign | not specified | 2020-01-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001410281 | SCV001612325 | likely benign | Long QT syndrome | 2024-08-28 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253779 | SCV002524823 | benign | Long QT syndrome 11 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002445412 | SCV002752993 | likely benign | Cardiovascular phenotype | 2019-12-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV001174574 | SCV001918671 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001724261 | SCV001952855 | likely benign | not provided | no assertion criteria provided | clinical testing |